It is known that for all adults, prevalence of potentially inappropriate prescribing (PIP) and
polypharmacy increases with advancing age and morbidity. This has been associated with …

Background Older people have a greater disease burden and are more likely than younger
to be prescribed medications. They are also more sensitive to adverse effects. With this in …

Background Adults with intellectual disability (ID) are prescribed high levels of medication,
with polypharmacy and psychotropic polypharmacy common. However, reported rates vary …

Given medical and social advances, the life expectancy of individuals with intellectual
disability (ID) has increased dramatically, leading to a generation of older individuals with …

Introduction Understanding the medication and supplement use of aging people is critical to
ensuring that health service providers in primary care can optimise use of these agents. An …

A growing expert consensus has emerged to guide prescribing behavior and monitoring of
psychotropic medications in adults and older adults with intellectual disability (ID). However …

Multimorbidity and polypharmacy are increasingly prevalent across healthcare systems and
settings as global demographic trends shift towards increased proportions of older people in …

Background: Polypharmacy and inappropriate prescription are frequent in vulnerable and
multi-morbid populations. Adults with intellectual disability (ID) are at risk of being …

Background People with intellectual disability (ID) are at increased risk of exposure to
psychotropic drugs and psychotropic polypharmacy because of the higher prevalence of …

Objectives (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive
polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical …